These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17210525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
    Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB.
    Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA, Bastacky SI, Myers EN, Hunt JL.
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [Abstract] [Full Text] [Related]

  • 6. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E, Li M.
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ.
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 10. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W, Tian B, Wu C, Peng Y, Wang H, Gu WL, Gao FH.
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [Abstract] [Full Text] [Related]

  • 11. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
    Gobbo S, Eble JN, Delahunt B, Grignon DJ, Samaratunga H, Martignoni G, Zhang S, Wang M, Brunelli M, Cossu-Rocca P, Cheng L.
    Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
    [Abstract] [Full Text] [Related]

  • 12. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J, Park CK, Kim M, Joo JW, Cho NH.
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [Abstract] [Full Text] [Related]

  • 13. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma.
    Krüger S, Sotlar K, Kausch I, Horny HP.
    Oncology; 2005 Mar; 68(2-3):269-75. PubMed ID: 16015044
    [Abstract] [Full Text] [Related]

  • 14. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC, Thomas DG, McHugh JB, Shah RB, Kunju LP.
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [Abstract] [Full Text] [Related]

  • 15. Collision renal tumors.
    Vasuri F, Fellegara G.
    Int J Surg Pathol; 2009 Aug; 17(4):338-9. PubMed ID: 18611936
    [No Abstract] [Full Text] [Related]

  • 16. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J, Yang X, Zhou L, Zhang P, Wang C.
    Dis Markers; 2019 Aug; 2019():4708154. PubMed ID: 31737127
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the KIT/stem cell factor axis in renal tumours.
    Horstmann M, Hennenlotter J, Geiger LM, Vogel U, Schmid H, Kuehs U, Stenzl A, Bedke J.
    Anticancer Res; 2012 Oct; 32(10):4339-45. PubMed ID: 23060556
    [Abstract] [Full Text] [Related]

  • 18. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
    Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH.
    Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
    [Abstract] [Full Text] [Related]

  • 19. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
    Mai KT, Kohler DM, Robertson SJ, Belanger EC, Marginean EC.
    Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
    [Abstract] [Full Text] [Related]

  • 20. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
    Waldert M, Klatte T, Haitel A, Ozsoy M, Schmidbauer J, Marberger M, Remzi M.
    Eur Urol; 2010 Apr; 57(4):661-5. PubMed ID: 19477583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.